Lets consider it a preliminary positive result.
Can't do it. I do admire your optimism. I agree, high marks that the study appears to suggest that res improves quality of life, but the question has always been about quantity.
A few people have mentioned that this is just one mouse strain. They certainly didn't select it because they thought it had the best chance for failure. These are the people who participated:
the laboratories of Rafael de Cabo, Ph.D., of the Laboratory of Experimental Gerontology at the NIA; David A. Sinclair, Ph.D., of the Glenn Laboratories for Molecular Biology of Aging at Harvard Medical School; and an international group of researchers. In addition to scientists from the NIA and Harvard Medical School, researchers from the following institutions collaborated in this study: New York Medical College, Valhalla, N.Y.; University of Michigan, Ann Arbor; University of Sydney in Australia; Thomas Jefferson University, Philadelphia; University of California, San Diego, La Jolla; Hospital for Special Surgery, New York, N.Y.; University of Cincinnati, Ohio; University of Texas Health Science Center at San Antonio and Audie Murphy VA Hospital, San Antonio, Texas; Universidad Pablo de Olavide, Sevilla, Spain; Pennington Biomedical Research Center, Baton Rouge, La.; University of Washington, Seattle; and Sirtris Pharmaceuticals of Cambridge, Mass., a company founded by Harvard University co-lead author Sinclair.
With a list this long you can bet they weren't looking to disprove any of their theories. There are a lot of positive things shaping up in LE; this is a big negative. Until they provide proof otherwise, the headline is Resveratrol Does Not Extend Lifespan in Mice.